I. Resche

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.

A. N. Serafini, S. J. Houston, I. Resche et al. · Journal of Clinical Oncology · 1998 · 432 citations

Monitoring of Early Response to Neoadjuvant Chemotherapy in Stage II and III Breast Cancer by [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography

Caroline Rousseau, Anne Devillers, Christine Sagan et al. · Journal of Clinical Oncology · 2006 · 310 citations · Full text

A dose-controlled study of 153Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastase

I. Resche, J.F. Chatal, A Pecking et al. · European Journal of Cancer · 1997 · 253 citations

Bone Disease, Medicine, Spinal Oncology +6

Treatment of bone metastases of prostate cancer with strontium-89 chloride: efficacy in relation to the degree of bone involvement

Françoise Kraeber‐Bodéré, L. Campion, Caroline Rousseau et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 134 citations

Surgical Oncology, Radiation Medicine, Urology +9

Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.

Françoise Kraeber‐Bodéré, Stéphane Bardet, Cornelis A. Hoefnagel et al. · PubMed · 1999 · 105 citations

Pharmacotherapy, Immunotherapy, Tumor Biology +18